Congrats Miriam Merad, MD, PhD Well-deserved!!

Congratulations Prof. Akiko Iwasaki and thank you for all you do for Immunology

Our CEO, Ken Drazan, MD, will speak on a panel - CAR T in Solid Tumors - at the Canaccord Genuity 2024 Horizons in Oncology Conference on April 15, 2024 at 10am EDT. ArsenalBio is focused on developing a new generation of #celltherapy medicines to treat solid tumor cancers

Crazy—we took a quick look at our platform data to see if it supported how it 'feels' out there. 2024 is on trend for the lowest programs against 'new drug targets' in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new

Memory genes are enriched in CAR T cells that persist and control tumors in patients. But which transcription factors drive beneficial memory programs?

We answer this in our lab’s first paper in nature led by Alex Doan Kat Mueller, PhD Andy Chen. 1/

nature.com/articles/s4158…

UPenn medical school names first vice dean of AI inquirer.com/health/upenn-m… via The Philadelphia Inquirer

An incredible talk ⁦by ⁦rising star ⁦Jennifer Guerriero, PhD⁩ ⁦Dana-Farber⁩ #aacr24 AACR⁩ annual meeting on targeting macrophages in the context of parp inhibition 👏👏👏

Penn proud as John Maris and John Wherry inducted into the 2024 Class of AACR fellows which recognizes distinguished scientists who have made major scientific innovations. Congrats AACR Penn Medicine Penn Medicine - Abramson Cancer Center E. John Wherry

Celebrating ⁦AACR⁩ w ⁦Padmanee (Pam) Sharma, MD, PhD⁩ ⁦Jim Allison PhD⁩ ⁦Miriam Merad, MD, PhD⁩ ⁦Dr. Ron DePinho⁩ ⁦AACRPres⁩ Phil Greenberg ⁦Jennifer Guerriero, PhD⁩ Elaine Mardis Jim Heath Bob Schreiber

Arsenal Biosciences is pleased to be presenting this week at the AACR Annual Meeting 2024. We look forward to share learnings from our #cancerresearch programs. Read our press release for more details: arsenalbio.com/2024/04/05/ars…

My favorite quote.

'I don't have talent, so I just get up earlier.' – Henry Rollins

Please, reviewers and authors:

Let’s not be ok with arbitrary flow cytometry gates that cut across normally distributed clusters. Even though flow cytometry is a single-cell assay, the data interpretation is largely at a population level because of variation in photon

Jane Yinghui Huang from the Wherry lab E. John Wherry defends tomorrow!

Some big news - I’m headed to Mass General Brigham Harvard Medical School Combined Derm Program for my residency training!

I owe everything to the amazing people at Penn Medicine (s/o E. John Wherry lab), PD Soros Fellowships, and my family + friends who made this possible

#Match2024

Excited to see this in Immunity! With Timothy Johnston, Grace Li, Hensley Lab, and E. John Wherry, we show how immune imprinting by mRNA vaccines enhances neutralizing responses to SARS-CoV-2 variants and how variant-specific responses can still emerge.
cell.com/immunity/fullt…

.Penn Medicine researchers receive $2.1M PolyBio grant to fund #longCOVID research ft. Sara Cherry (@PennPathLabMed), E. John Wherry (@pennsyspharmatt) & Locci Lab (@PennMicro) UPenn I3H tinyurl.com/3jz9ry4a

#ICYMI : Check out the latest from the Penn Medicine #LunchwithLeaders series, ft'ing a conversation between E. John Wherry (@PennSysPharmATT/ UPenn I3H) & Cindy Morgan (UPHS) on the origin story behind Dr. Wherry's groundbreaking work in immunology tinyurl.com/mr34csc3

So excited for this next round of PolyBio LongCOVID work. We are thrilled to be working with PolyBio and all the amazing scientists who are part of this effort.

I can't overstate the value of efforts like this to do rigorous and collaborative research on Long COVID. I'm really grateful to be working as part of this consortium!

Huge congrats to Cathy Wu for the Sjöberg Prize and wonderful coverage today on CNN. Very well-deserved. Cathy is a truly groundbreaking scientist and also exceptional human being. Bringing more immunology to more cancer patients.

cnn.com/2024/02/20/hea…